CytomX Therapeutics' Debt Round

CytomX Therapeutics raised a round of funding on January 13, 2009.

CytomX Therapeutics is a biotechnology company developing Probody therapeutics for the treatment of cancer. Probodies are masked antibodies that remain inert in healthy tissue but are activated specif…

Articles about CytomX Therapeutics' Debt Round: